SEC Form 4 · accession 0001225208-16-027812
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paula A Johnson
Director
Period of report
Feb 23, 2016
Accepted (ET)
Feb 24, 2016 · 2:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 23, 2016 | M | 7,800 | $18.05 | A | 46,893 | D | |
| Common Stock | Feb 23, 2016 | S | 7,800 | $59.3934 | D | 39,093 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $18.05 | Feb 23, 2016 | M | 7,800 | D | May 2, 2007 | May 2, 2016 | Common Stock | 7,800 | 0 | D |
Explanation of responses
- F1Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.